Amyris to revise artemisinin route | Chemical & Engineering News
Volume 94 Issue 16 | p. 15 | Concentrates
Issue Date: April 18, 2016

Amyris to revise artemisinin route

Department: Business
Keywords: drug development, biotechnology, malaria, drug development
[+]Enlarge
An Amyris researcher examines genetically modified microbes under a microscope.
Credit: Amyris
A photo of an Amryis researcher examining genetically modified microbes under a microscope.
 
An Amyris researcher examines genetically modified microbes under a microscope.
Credit: Amyris

Industrial biotechnology firm Amyris will work to reduce the cost of making the malaria treatment artemisinin via fermentation with help from a $5 million investment from the Bill & Melinda Gates Foundation. The company first developed its biotech route to the drug in 2005. The product is also derived from the herb sweet wormwood, but supplies are subject to shortages.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment